Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 6, 2010, Pages 670-677

  Laule, C ^a   Vavasour, I M ^a   Zhao, Y ^a   Traboulsee, A L ^a   Oger, J ^a   Vavasour, J D ^a   MacKay, A L ^a   Li, D K B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Atrophy; Demyelination; MRI; Multiple sclerosis; Spinal cord

Indexed keywords

GADOLINIUM; GLATIRAMER; MYELIN; PLACEBO; IMMUNOSUPPRESSIVE AGENT; PEPTIDE;

ADULT; AGED; ARTICLE; BRAIN SIZE; CERVICAL SPINAL CORD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; THERAPY EFFECT; THREE DIMENSIONAL IMAGING; WHITE MATTER; ATROPHY; BODY WATER; BRAIN; CERVICAL SPINE; CHEMISTRY; DRUG EFFECTS; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MYELIN SHEATH; ORGAN SIZE; PATHOLOGY; REPRODUCIBILITY; SPINAL CORD; TREATMENT OUTCOME;

ADULT; AGED; ATROPHY; BODY WATER; BRAIN; CERVICAL VERTEBRAE; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MYELIN SHEATH; ORGAN SIZE; PEPTIDES; REPRODUCIBILITY OF RESULTS; SPINAL CORD; TREATMENT OUTCOME;

EID: 77953783446     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510365586     Document Type: Article

References (29)

1. Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998 ; 121: 687-697.
2. Kidd D., Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993 ; 43: 2632-2637. (Pubitemid 24004558)
3. Filippi M., Campi A., Colombo B., et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996 ; 243: 502-505. (Pubitemid 26239702)
4. Liu C., Edwards S., Gong Q., Roberts N., Blumhardt LD Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999 ; 66: 323-330.
5. Losseff NA, Webb SL, ORiordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996 ; 119: 701-708.
6. Bieniek M., Altmann DR, Davies GR, et al. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006 ; 77: 1036-1039.
7. Agosta F., Absinta M., Sormani MP, et al. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain 2007 ; 130: 2211-2219.
8. Stevenson VL, Leary SM, Losseff NA, et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 1998 ; 51: 234-238.
9. Lin X., Tench CR, Turner B., Blumhardt LD, Constantinescu CS Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry 2003 ; 74: 1090-1094.
10. Webb S., Munro CA, Midha R., Stanisz GJ Is multicomponent T2 a good measure of myelin content in peripheral nerve? Mag Reson Med 2003 ; 49: 638-645.
11. Laule C., Leung E., Lis DK, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 2006 ; 12: 747-753.
12. Laule C., Kozlowski P., Leung E., et al. Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology. Neuroimage 2008 ; 40: 1575-1580.
13. MacKay A., Whittall K., Adler J., et al. In vivo visualization of myelin water in brain by magnetic resonance. Mag Reson Med 1994 ; 31: 673-676.
14. Whittall KP, MacKay AL, Graeb DA, et al. In vivo measurement of T2 distributions and water contents in normal human brain. Mag Reson Med 1997 ; 37: 34-43.
15. Laule C., Vavasour IM, Moore GRW, et al. Water content and myelin water fraction in multiple sclerosis: A T2 relaxation study. J Neurol 2004 ; 251: 284-293.
16. Minty EP, Bjarnason TA, Laule C., Mackay AL Myelin water measurement in the spinal cord. Magn Reson Med 2009 ; 61: 883-892.
17. Wu Y., Alexander AL, Fleming JO, Duncan ID, Field AS Myelin water fraction in human cervical spinal cord in vivo. J Comput Assist Tomogr 2006 ; 30: 304-306.
18. MacMillan EL, Maedler B., Kolind SH, Yip E., MacKay AL 3D myelin water imaging in the human spinal cord at 3.0T. In: Proceedings of the International Society of Magnetic Resonance in Medicine. Berlin: Germany, 2007.
19. MacMillan EL, Curt A., Maedler B., Li DKB, Dvorak MF, MacKay AL 3D myelin water imaging of cervical spondylotic myelopathy at 3T. In: Proceedings of the ISMRM. Toronto: Canada, 2008.
20. Wolinsky JS, Narayana PA, OConnor P., et al. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol 2007 ; 61: 14-24.
21. Bedell BJ, Narayana PA, Wolinsky JS A dual approach for minimizing false lesion classifications on magnetic resonance images. Magn Reson Med 1997 ; 37: 94-102.
22. Wolinsky J., Narayana P., He R. Overview of treatment trials: early baseline clinical and MRI data of the PROMiSe trial. In: Filippi M, Comi G (eds), Primary progressive multiple sclerosis. Milan: Springer-Verlag, 2002, pp. 47-62.
23. Whittall KP, MacKay AL Quantitative interpretation of NMR relaxation data. J Mag Reson 1989 ; 84: 134-152.
24. Beaulieu C., Fenrich FR, Allen PS Multicomponent water proton transverse relaxation and T2-discriminated water diffusion in myelinated and nonmyelinated nerve. Magn Reson Imaging 1998 ; 16: 1201-1210.
25. Fenrich FR, Beaulieu C., Allen PS Relaxation times and microstructures. NMR Biomed 2001 ; 14: 133-139.
26. Gareau PJ, Rutt BK, Karlik SJ, Mitchell JR Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Mag Reson Imaging 2000 ; 11: 586-595.
27. Graham SJ, Stanchev PL, Bronskill MJ Criteria for analysis of multicomponent tissue T2 relaxation data. Mag Reson Med 1996 ; 35: 370-378.
28. Gilmore CP, DeLuca GC, Bo L., et al. Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch Neurol 2005 ; 62: 1859-1862.
29. Filippi M., Colombo B., Rovaris M., et al. A longitudinal magnetic resonance imaging study of the cervical cord in multiple sclerosis. J Neuroimaging 1997 ; 7: 78-80.